Information provision for people with multiple sclerosis

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 4, 2014, Pages

  Köpke, Sascha ^a   Solari, Alessandra ^b   Khan, Fary ^c   Heesen, Christoph ^d   Giordano, Andrea ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DAILY LIFE ACTIVITY; DECISION MAKING; EXPANDED DISABILITY STATUS SCALE; FAMILY PLANNING; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SERVICE; HOSPITAL ADMISSION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MEDICAL EDUCATION; MEDICAL INFORMATION; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SELF CARE; SYSTEMATIC REVIEW; CONSUMER HEALTH INFORMATION; PATIENT EDUCATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CONSUMER HEALTH INFORMATION; DECISION MAKING; HUMANS; MULTIPLE SCLEROSIS; PATIENT EDUCATION AS TOPIC; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84906243071     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008757.pub2     Document Type: Review

References (133)

1. Ennis M, Thain J, Boggild M, Baker G, Young C. A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. Clinical Rehabilitation 2006;20(9):783-92.
2. Kasper J, Köpke S, Mühlhauser I, Nübling M, Heesen C. Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): a randomized controlled trial. European Journal of Neurology 2008;15(12):1345-52.
3. Köpke S, Kasper J, Mühlhauser I, Nübling M, Heesen C. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial. Multiple Sclerosis 2009;15(1):96-104.
4. Köpke S, Kern S, Ziemssen T, Berghoff M, Kleiter I, Marziniak M, et al.Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry 2013 Oct 8 [Epub ahead of print].
5. Kos D, Duportail M, D'hooghe M, Nagels G, Kerckhofs E. Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial. Multiple Sclerosis 2007;13(8):996-1003.
6. O'Hara L, Cadbury H, De Souza L, Ide L. Evaluation of the effectiveness of professionally guided self-care for people with multiple sclerosis living in the community: a randomized controlled trial. Clinical Rehabilitation 2002;16(2):119-28.
7. Prunty MC, Sharpe L, Butow P, Fulcher G. The motherhood choice: a decision aid for women with multiple sclerosis. Patient Education and Counseling 2008;71(1):108-15.
8. Shinto L, Calabrese C, Morris C, Yadav V, Griffith D, Frank R, et al.A randomized pilot study of naturopathic medicine in multiple sclerosis. Journal of Alternative and Complementary Medicine 2008;14(5):489-96.
9. Solari A, Martinelli V, Trojano M, Lugaresi A, Granella F, Giordano A, et al.An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. Multiple Sclerosis 2010;16(11):1393-405.
10. Young FK, Brooks BR. Patient teaching manuals improve retention of treatment information--a controlled clinical trial in multiple sclerosis. Journal of Neuroscience Nursing 1986;18(1):26-8.
11. Berger BA, Liang H, Hudmon KS. Evaluation of software-based telephone counseling to enhance medication persistency among patients with multiple sclerosis. Journal of the American Pharmaceutical Association 2005;45(4):466-72.
12. Bombardier CH, Cunniffe M, Wadhwani R, Gibbons LE, Blake KD, Kraft GH. The efficacy of telephone counseling for Health Promotion in people with Multiple Sclerosis: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2008;89:1849-56.
13. Bombardier CH, Ehde DM, Gibbons LE, Wadhwani R, Sullivan MD, Rosenberg DE, et al.Telephone-based physical activity counseling for major depression in people with multiple sclerosis. Journal of Consulting and Clinical Psychology 2013;81(1):89-99.
14. Burgess M, Andiappan M, Chalder T. Cognitive behaviour therapy for chronic fatigue syndrome in adults: face to face versus telephone treatment: a randomized controlled trial. Behavioural and Cognitive Psychotherapy 2012;40(2):175-91.
15. Christopherson JM, Moore K, Foley FW, Warren KG. A comparison of written materials vs. materials and counselling for women with sexual dysfunction and multiple sclerosis. Journal of Clinical Nursing 2006;15:742-50.
16. Cosio D, Jin L, Siddique J, Mohr DC. The effect of telephone-administered cognitive-behavioral therapy on quality of life among patients with multiple sclerosis. Annals of Behavioral Medicine 2011;41(2):227-34.
17. Dlugonski D, Motl RW, Mohr DC, Sandroff BM. Internet-delivered behavioral intervention to increase physical activity in persons with multiple sclerosis: sustainability and secondary outcomes. Psychology, Health & Medicine 2012;17(6):636-51.
18. Finlayson M, Preissner K, Cho C, Plow M. Randomized trial of a teleconference-delivered fatigue management program for people with multiple sclerosis. Multiple Sclerosis 2011;17(9):1130-40.
19. Forman AC, Lincoln NB. Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clinical Rehabilitation 2010;24(3):211-21.
20. Garber SL, Rintala DH, Holmes SA, Rodriguez GP, Friedman J. A structured educational model to improve pressure ulcer prevention knowledge in veterans with spinal cord dysfunction. Journal of Rehabilitation Research and Development 2002;39:575-88.
21. Ghahari S, Leigh Packer T, Passmore AE. Effectiveness of an online fatigue self-management programme for people with chronic neurological conditions: a randomized controlled trial. Clinical Rehabilitation 2010;24(8):727-44.
22. Hill S, Filippini G, Synnot A, Summers M, Beecher D, Colombo C, et al.Presenting evidence-based health information for people with multiple sclerosis: the IN-DEEP project protocol. BMC Medical Informatics and Decision Making 2012;12:1-8.
23. Mattioli F, Stampatori C, Scarpazza C, Parrinello G, Capra R. Persistence of the effects of attention and executive functions intensive rehabilitation in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 2012;1(4):168-73.
24. McAuley E, Motl RW, Morris KS, Hu L, Doerksen SE, Elavsky S, et al.Enhancing physical activity adherence and well-being in multiple sclerosis: a randomised controlled trial. Multiple Sclerosis 2007;13(5):652-9.
25. McClurg D, Hagen S, Hawkins S, Lowe-Strong A. Abdominal massage for the alleviation of constipation symptoms in people with multiple sclerosis: a randomized controlled feasibility study. Multiple Sclerosis 2011;17(2):223-33.
26. Miller DM, Moore SM, Fox RJ, Atreja A, Fu AZ, Lee JC, et al.Web-based self-management for patients with multiple sclerosis: a practical, randomized trial. Telemedicine Journal and e-Health 2011;17(1):5-13.
27. Möller H, Deppe R, Faiss J, Faiss JH, Hoffmann F, Klauer T, et al.[Psychoedukatives Bewaltigungstraining für Patienten mit Multipler Sklerose (MS): Entwicklung und Evaluation]. Proceedings of the Deutsche Gesellschaft für Neurologie; 2010 Dec 10-12. Rostock-Warnemünde, 2010.
28. Moss-Morris R, McCrone P, Yardley L, van Kessel K, Wills G, Dennison L. A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue. Behaviour Research and Therapy 2012;50(6):415-21.
29. Rigby SA, Thornton EW, Young CA. A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis. British Journal of Health Psychology 2008;13:619-31.
30. Ward CD, Turpin G, Dewey ME, Fleming S, Hurwitz B, Ratib S, et al.Education for people with progressive neurological conditions can have negative effects: evidence from a randomized controlled trial. Clinical Rehabilitation 2004;18:717-25.
31. Wassem R, Dudley W. Symptom management and adjustment of patients with multiple sclerosis: a 4-year longitudinal intervention study. Clinical Nursing Research 2003;12(1):102-17.
32. Rotstein D, Evans M, Hohol M, O'Connor P. A randomized, controlled trial of an educational intervention for MS patients concerning CCSVI. Neurology 2012;78(Meeting Abstracts 1):P05.128.
33. Airlie J, Baker G, Smith S, Young C. Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale. Clinical Rehabilitation 2001;15:259-65.
34. Ajzen I. From intentions to actions: A theory of planned behaviour. In: Kuhl J, Beckmann J editor(s). Action control: From cognition to behaviour. New York: Springer-Verlag, 1985:11-39.
35. Bandura A. Self-efficacy: toward a unifying theory of behavioural change. Psychological Review 1977;84:191-215.
36. Beck A, Ward CH, Medelson M, Mock J. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561-71.
37. Becker H, Stuifbergen AK, Oh HS, Hall S. Self-rated abilities for health practices: a health self-efficacy measure. Health Values 1993;17:42-50.
38. Boer H, Seydel ER. Protection motivation theory. In: Connor M, Norman P editor(s). Predicting health behavior. Vol. 20, Buckingham: Open University Press, 1996:95-120.
39. Borreani C, Giordano A, Falautano M, Lugaresi A, Martinelli V, Granella F, et al.Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial. Health Expectations 2014; Vol. 17, issue 1:36-48. [DOI:].
40. Bruce JM, Hancock LM, Arnett P, Lynch S. Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. Journal of Behavioral Medicine 2010;33:219-27.
41. Buchholz A, Hölzel L, Kriston L, Simon D, Harter M. German-language version of Decisional Conflict Scale (DCS-D). Dimensional structure in a sample of family physician patients. Klinische Diagnostik und Evaluation 2011;4:15-30.
42. Bunge M, Mühlhauser I, Steckelberg A. What constitutes evidence-based patient information? overview of discussed criteria. Patient Education and Counseling 2010;78:316-28.
43. Burton JM, O'Connor PW, Hohol M, Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI:].
44. Campbell M, Fitzpatrick R, Haines A, Kinmonth A, Sandercock P, Spiegelhalter D, et al.Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-6.
45. Campbell N, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al.Designing and evaluating complex interventions to improve health care. BMJ 2007;334:455-9.
46. Cardol M, de Haan RJ, van den Bos GA, De Jong BA, de Groot IJ. The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA). Clinical Rehabilitation 1999;13:411-9.
47. Cochrane Consumers and Communication Review Group. Outcomes of Interest to the Cochrane Consumers and Communication Review Group. www.latrobe.edu.au/chcp/assets/downloads/Outcomes.pdf (accessed 26 June 2010).
48. Compston A, Coles A. Multiple Sclerosis. Lancet 2008;372:1502-17.
49. Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: is the information good enough?. BMJ 1999;318:318-22.
50. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655.
51. De Souza L. The development of a scale of the Guttman Type for the assessment of mobility disability in multiple sclerosis. Clinical Rehabilitation 1999;13:476-81.
52. Degenhardt A, Ramagopalan SV, Scalfari A, Ebers GC. Clinical prognostic factors in multiple sclerosis: a natural history review. Nature Reviews Neurology 2009;5:672-82.
53. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Canadian Journal of Nursing Research 1997;29:21-43.
54. Demaille-Wlodyka S, Donze C, Givron P, Gallien P, ETP Sofmer Group. Self care programs and multiple sclerosis: physical therapeutics treatment - literature review. Annals of Physical and Rehabilitation Medicine 2011;54:109-28.
55. Ebers GC, Traboulsee A, Li D, Langdon D, Reder AT, Goodin DS, et al.Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial. Journal of Neurology, Neurosurgery, and Psychiatry 2010;81(8):907-12.
56. Elwyn G, Hutchings H, Edwards A, Rapport F, Wensing M, Cheung W, et al.The OPTION scale: measuring the extent that clinicians involve patients in decision-making tasks. Health Expectations 2005;8:34-42.
57. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al.Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006;333:417-9.
58. European Multiple Sclerosis Platform. European Code of Good Practice on the rights and quality of life of people affected by multiple sclerosis. 2008. www.ms-in-europe.com/w3p_dokumentearchiv/1code08.pdf (accessed 26 June 2010).
59. Filippini G, Munari L, Incorvaia B, Ebers G, Polman C, D'Amico R, et al.Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003;361:545-52.
60. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. Clinical Infectious Diseases 1994;14:S79-83.
61. Forster A, Brown L, Smith J, House A, Knapp P, Wright JJ, et al.Information provision for stroke patients and their caregivers. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI:].
62. Freedman M, Hughes B, Mikol D, Bennett R, Cuffel B, Divan V, et al.Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: a systematic comparison. European Journal of Neurology 2008;60:1-11.
63. Freedman M. "Time is brain" also in multiple sclerosis. Multiple Sclerosis 2009;15(10):1133-4.
64. Giordano A, Mattarozzi K, Pucci E, Leone M, Casini F, Collimedaglia L, et al.Participation in medical decision-making: attitudes of Italians with multiple sclerosis. Journal of Neurological Sciences 2008;275:86-91.
65. Giordano A, Uccelli M, Pucci E, Martinelli V, Borreani C, Lugaresi A, et al.The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients. Multiple Sclerosis 2010;16(1):100-11.
66. Giordano A, Lugaresi A, Confalonieri P, Granella F, Radice D, Trojano M, et al.Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial. Multiple Sclerosis Jan 14 [Epub ahead of print]. [DOI:].
67. Gold S, Heesen C, Schulz H, Guder U, Mönch A, Gbadamosi J, et al.Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Multiple Sclerosis 2001;7:119-30.
68. Goretti B, Portaccio E, Zipoli V, Hakiki B, Siracusa G, Sorbi S, et al.Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurological Sciences 2009;30:15-20.
69. Gronwall DMA. Paced auditory serial-addition task: A measure of recovery from concussion. Perceptual and Motor Skills 1977;44:356-73.
70. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al.GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94.
71. Heesen C, Kolbeck J, Gold S, Schulz H, Schulz K. Delivering the diagnosis of MS - results of a survey among patients and neurologists. Acta Neurologica Scandinavica 2003;107:363-8.
72. Heesen C, Kasper J, Segal J, Köpke S, Mühlhauser I. Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis. Multiple Sclerosis 2004;10:643-50.
73. Heesen C, Kasper J, Köpke S, Richter T, Segal J, Mühlhauser I. Informed shared decision making in multiple sclerosis - inevitable or impossible?. Journal of the Neurological Sciences 2007;259:109-17.
74. Heesen C, Reich C, Borchers C, Gold SM, Schulz KH. Patient based scoring instruments in multiple sclerosis - German validation of the United Kingdom Disability Scale and the Patient Generated Index. Neurologie & Rehabilitation 2007;13:24-36.
75. Heesen C, Kleiter I, Nguyen F, Schaffler N, Kasper J, Köpke S, et al.Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists. Multiple Sclerosis 2010;16:1507-12.
76. Heesen C, Solari A, Giordano A, Kasper J, Köpke S. Decisions on multiple sclerosis immunotherapy: new treatment complexities urge patient engagement. Journal of the Neurological Sciences 2011;306:192-7.
77. Heesen C, Köpke S, Kasper J, Poettgen J, Tallner A, Mohr DC, et al.Behavioral interventions in multiple sclerosis: a biopsychosocial perspective. Expert Review of Neurotherapeutics 2012;12:1089-100.
78. Higgins J, Greene S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
79. Kasper J, Köpke S, Mühlhauser I, Heesen C. Evidence-based patient information about treatment of multiple sclerosis. A phase one study on comprehension and emotional responses. Patient Education and Counseling 2006;62:56-63.
80. Kasper J, Heesen C, Köpke S, Fulcher G, Geiger F. Patients' and observers' perceptions of involvement differ. Validation study on inter-relating measures for shared decision making. www.plosone.org 2011 (accessed 12 June 2013); Vol. 6:e26255.
81. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology 1989;46:1121-23.
82. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
83. Köpke S, Heesen C, Kasper J, Mühlhauser I. Steroid treatment for relapses in multiple sclerosis - the evidence urges shared decision-making. Acta Neurologica Scandinavica 2004;110:1-5.
84. Köpke S, Solari A, Khan F, Heesen C, Giordano A. Information provision for persons with multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2010;10:CD008757.
85. Köpke S, Richter T, Kasper J, Mühlhauser I, Flachenecker P, Heesen C. Implementation of a patient education program on multiple sclerosis relapse management. Patient Education and Counseling 2012;86:91-7.
86. Lawson A, Robinson I, Bakes C. Problems in evaluating the consequences of disabling illness: the case of multiple sclerosis. Psychological Medicine 1985;15:555-79.
87. Li T, Wu H, Wang F, Huang C, Yang M, Dong B, et al.Education programmes for people with diabetic kidney disease. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI:].
88. Lohaus A, Schmidt G. KKG Questionnaire. Göttingen: Hogrefe, 1989.
89. Marge M. Health promotion for persons with disabilities: moving beyond rehabilitation. American Journal of Health Promotion 1988;2:29-44.
90. Marteau T, Dormandy E, Michie S. A measure of informed choice. Health Expectations 2001;4:99-108.
91. Meyer H. Unterichtsmethoden [Teaching methods]. Frankfurt: Cornelsen Scriptor, 1983.
92. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Paralyzed Veterans of America 1998.
93. Mulley AG, Trimble C, Elwyn G. Stop the silent misdiagnosis: patients' preferences matter. BMJ 2012;345:1-6.
94. Multiple Sclerosis International Federation. Atlas of MS. www.atlasofms.org (accessed 26 June 2010).
95. Möhler R, Bartoszek G, Köpke S, Meyer G. Proposed criteria for reporting the development and evaluation of complex interventions in healthcare (CReDECI): guideline development. International Journal of Nursing Studies 2012;49(1):40-6.
96. The National Collaborating Centre for Chronic Conditions (NCC-CC). Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care 2004. www.rcplondon.ac.uk/pubs/books/MS/MSfulldocument.pdf (accessed 26 June 2010).
97. O'Connor A. Validation of a decisional conflict scale. Medical Decision Making 1995;15:25-30.
98. O'Connor AM. User Manua - Decision self-efficacy scale. http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decision_SelfEfficacy.pdf (accessed 20 November 2004).
99. O'Hara L, De Souza LH, Ide L. A delphi study of self-care in a community population of people with multiple sclerosis. Clinical Rehabilitation 2000;14:62-71.
100. Otto C, Bischof G, Rumpf HJ, Meyer C, Hapke U, John U. Multiple dimensions of health locus of control in a representative population sample: ordinal factor analysis and cross-validation of an existing three and a new four factor model. BMC Medical Research Methodology 2011;11:114.
101. Pender NJ. Health promotion in nursing practice. Appleton & Lange, 1987.
102. Perret E. The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour. Neuropsychologia 1974;12:323-30.
103. Pietrolongo E, Giordano A, Kleinefeld M, Confalonieri P, Lugaresi A, Tortorella C, et al.Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments. PLoS One 2013; Vol. 8, issue 4:e60721.
104. Plow M, Finlayson M, Rezac M. A scoping review of self-management interventions for adults with multiple sclerosis. PM & R 2011;3:251-62.
105. Polman C, Reingold S, Edan G, Filippi M, Hartung H, Kappos L, et al.Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of Neurology 2005;58:840-6.
106. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al.Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology 2011;69:292-302.
107. Poser C, Paty D, Scheinberg L, McDonald W, Davis F, Ebers G, et al.New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 1983;13:227-31.
108. Prunty M, Sharpe L, Butow P, Fulcher G. The motherhood choice: themes arising in the decision-making process for women with multiple sclerosis. Multiple Sclerosis 2008;14:701-4.
109. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385-401.
110. Ramsaransing G, De Keyser J. Benign course in multiple sclerosis: a review. Acta Neurologica Scandinavica 2006;113:359-69.
111. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013.
112. Riemsma R, Kirwan J, Taal E, Rasker J. Patient education for adults with rheumatoid arthritis. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI:].
113. Ritvo PG, Fischer JS, Miller DM, Andrews H, Paty DW, LaRocca NG. Multiple sclerosis quality of life inventory: a user's manual. http://walkcoc.nationalmssociety.org/docs/HOM/MSQLI_Manual_and_Forms.pdf (accessed 28 February 2014).
114. Robinson I, Hunter M, Neilson S. A dispatch from the frontline: The views of people with multiple sclerosis about their needs: a qualitative approach. A report for the MS Society. London: MS Society, 1996.
115. Rogers R. A protection motivation theory of fear appeals and attitude change. Journal of Psychology 1975;91:93-114.
116. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 1997;314:1580-3.
117. Rudick RA, Cutter G, Reingold S. The multiple sclerosis functional composite: A new clinical outcome measure for multiple sclerosis trials. Multiple Sclerosis 2002;8:359-65.
118. Schumacher G, Beebe G, Kebler R, Kurland L, Kurtzke J, McDowell F, et al.Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Annals of the New York Academy of Sciences 1965;122:552-68.
119. Schwartz CE, Coulthard-Morris L, Zeng Q, Retzlaff P. Measuring self-efficacy in people with multiple sclerosis: a validation study. Archives of Physical Medicine and Rehabilitation 1996;77:394-8.
120. Schaffler N, Köpke S, Winkler L, Schippling S, Inglese M, Fischer K, et al.Accuracy of diagnostic tests in multiple sclerosis, a systematic review. Acta Neurologica Scandinavica 2011;124:151-64.
121. Sharrack B, Hughes RA. The Guy's NeurologicalDisability Scale (GNDS): a new disability measure for multiple sclerosis. Multiple Sclerosis 1999;5:223-33.
122. Shinto L, Calabrese C, Morris C, Sinsheimer S, Dennis R. Complementary and alternative medicine in multiple sclerosis: Survey of licensed naturopaths. Journal of Alternative and Complementary Medicine 2004;10:891-7.
123. Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, et al.Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA 201;308:247-56.
124. Simon D, Schorr G, Wirtz M, Vodermaier A, Caspari C, Neuner B, et al.Development and first validation of the shared decision-making questionnaire (SDM-Q). Patient Education and Counseling 2006;63:319-27.
125. Solari A, Acquarone N, Pucci E, Martinelli V, Marrosu MG, Trojano M, et al.Communicating the diagnosis of multiple sclerosis - a qualitative study. Multiple Sclerosis 2007;13:763-9.
126. Solari A, Mattarozzi K, Vignatelli L, Giordano A, SIMS-Trial group, GERONIMUS group. Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. Multiple Sclerosis 2010;16(10):1237-47.
127. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, et al.Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI:].
128. Steckelberg A, Berger B, Köpke S, Heesen C, Mühlhauser I. Criteria for evidence-based patient information [Kriterien für evidenzbasierte Patienteninformationen]. Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung 2005;99:343-51.
129. Vickrey B, Hays R, Genovese B, Myers L, Ellison G. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. Journal of Clinical Epidemiology 1997;50:557-69.
130. Vickrey B, Shatin D, Wolf S, Myers L, Belin T, Hanson R, et al.Management of multiple sclerosis across managed care and fee-for-service systems. Neurology 2000;55:1341-9.
131. Walker SN, Sechrist KR, Pender NJ. The Health Promoting Lifestyle Profile: development and psychometric characteristics. Nursing Research 1987;36:76-81.
132. Whiting P, Harbord R, Main C, Deeks J, Filippini G, Egger M, et al.Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review. BMJ 2006;332:875-84.
133. Wollin J, Dale H, Spenser N, Walsh A. What people with newly diagnosed MS (and their families and friends) need to know. International Journal of MS Care 2000;2:4-14.